StockWatch
·
Pharmaceuticals
Board Meeting7 Nov 2026, 03:40 pm

Phaarmasia Ltd Board Meeting on Nov 12 to Approve Q2 Results

AI Summary

Phaarmasia Ltd has announced that its Board of Directors will convene on November 12, 2026, at 4:00 PM via video conference. The primary agenda items include the consideration and approval of the un-audited financial results for the quarter and half-year ended September 30, 2026, along with the Limited Review Report. The board will also review related party transactions and take note of the company's operations and a compliance certificate from the CEO and CFO.

Key Highlights

  • Board meeting scheduled for November 12, 2026.
  • To approve un-audited financial results for Q2 and H1 FY27.
  • Review of related party transactions is on the agenda.
  • Compliance certificate from CEO and CFO to be noted.